XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Column Expands Stablecoin Card Issuing to Rival Mastercard, Marqeta
Column, a banking infrastructure provider, is expanding its stablecoin card issuing capabilities in a move that positions it as a direct competitor to establish...
Trump Demands 3% Rate Drop, Cites Warsh Hike Threats
President Donald Trump has called for a 3% reduction in interest rates, escalating his public feud with Federal Reserve leadership by pointing to Fed Governor K...
Bitcoin Strategic Reserve Bill Heads to House Markup Vote
In the US legislative process, a committee markup is the stage at which the sponsoring committee formally considers proposed legislation. Members can offer amen...
Fed Hikes Rates for First Time Since 2023, Signals More Ahead
The Federal Reserve raised interest rates for the first time since 2023 and indicated that additional increases could follow, marking a notable shift in the cen...
XRP Falls After Senate Fails to Advance CLARITY Act
XRP fell after the Senate failed to advance the CLARITY Act, dealing a setback to crypto-market participants who had priced in the prospect of clearer digital-a...
CFTC Chairman Says US Is Ready for New Crypto Regulations
The Senate voted 49-50 on September 15 against advancing the CLARITY Act; the bill required 60 votes to move forward. For related coverage, see SEC Chair Paul A...
